Literature DB >> 15105451

Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.

Gottfried J Schaffler1, Gerald Wolf, Helmut Schoellnast, Reinhard Groell, Alfred Maier, Freya M Smolle-Jüttner, Michael Woltsche, Gerlinde Fasching, Rudolf Nicoletti, Reingard M Aigner.   

Abstract

PURPOSE: To evaluate the accuracy of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiation of pleural malignancy and cancer-unrelated pleural disease in patients with non-small cell lung cancer (NSCLC) and pleural abnormalities at computed tomography (CT).
MATERIALS AND METHODS: In 92 patients, pleural abnormalities were detected at contrast material-enhanced thoracic CT, which was performed for newly diagnosed NSCLC (n = 41) or restaging (n = 51). CT findings were negative for pleural malignancy when pleural effusion with attenuation of 10 HU or less and/or rib fractures with no evidence of pathologic fracture were present; findings were indeterminate when pleural effusion with attenuation greater than 10 HU and/or solid pleural abnormalities without osseous destruction of the chest wall were present; and findings were positive if any osseous destruction of the chest wall adjacent to a pleural mass was present. All patients underwent FDG PET. Findings were negative for pleural malignancy if pleural activity was absent, equal to, or less than mediastinal background activity; findings were positive if pleural activity was higher than mediastinal background activity. Reading of CT and FDG PET scans was first performed separately and then was combined. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPP), and accuracy were calculated for CT and FDG PET separately and for CT and FDG PET combined, with cytologic and/or histologic analysis as standard of reference.
RESULTS: In detection of pleural malignancies, CT findings were indeterminate in 65 (71%) patients and true-negative in 27 (29%). Respective sensitivity, specificity, PPV, NPV, and accuracy of FDG PET in detection of pleural malignancies were 100%, 71%, 63%, 100%, and 80%; and those of CT and FDG PET combined, 100%, 76%, 67%, 100%, and 84%.
CONCLUSION: Findings suggest that a negative FDG PET scan for indeterminate pleural abnormalities at CT indicates a benign character, while positive findings on an FDG PET scan are sensitive for malignancy. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105451     DOI: 10.1148/radiol.2313030785

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

Review 1.  Role of positron emission tomography-computed tomography in non-small cell lung cancer.

Authors:  Pankaj Kumar Garg; Saurabh Kumar Singh; Gaurav Prakash; Ashish Jakhetiya; Durgatosh Pandey
Journal:  World J Methodol       Date:  2016-03-26

2.  18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.

Authors:  Hiroaki Toba; Shoji Sakiyama; Hideki Otsuka; Yukikiyo Kawakami; Hiromitsu Takizawa; Koichiro Kenzaki; Kazuya Kondo; Akira Tangoku
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-21

3.  Bayesian Estimation of Combined Accuracy for Tests with Verification Bias.

Authors:  Lyle D Broemeling
Journal:  Diagnostics (Basel)       Date:  2011-12-15

4.  Imaging of lung cancer: Implications on staging and management.

Authors:  Nilendu C Purandare; Venkatesh Rangarajan
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 5.  Bayesian Methods for Medical Test Accuracy.

Authors:  Lyle D Broemeling
Journal:  Diagnostics (Basel)       Date:  2011-05-05

6.  [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].

Authors:  Riqiang Liao; Xuening Yang; Siyun Wang; Qing Zhou; Qiang Nie; Wenzhao Zhong; Song Dong; Yilong Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-11

7.  Positron emission tomography in the management of lung cancer.

Authors:  Vahid Reza Dabbagh Kakhki
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

8.  Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.

Authors:  Reiko Nakajima; Koichiro Abe; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

9.  The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.

Authors:  Yajuan Sun; Hongjuan Yu; Jingquan Ma; Peiou Lu
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

10.  Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Authors:  Da Hyun Kang; Chaeuk Chung; Ju-Ock Kim; Sung Soo Jung; Hee Sun Park; Dong Il Park; Sun Young Jung; Myoungrin Park; Jeong Eun Lee
Journal:  Thorac Cancer       Date:  2018-09-25       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.